The potential of Precision Medicine

〈http://www.genomicsengland.co.uk/uk-to-become-world-number-one-in-dna-testing-with-plan-to-revolutionise-fight-against-cancer-and-rare-diseases/〉. 〈https://www.nih.gov/precision-medicine-initiative-cohort-program〉. 〈http://shgp.kacst.edu.sa〉. 〈http://www.gulf-times.com/qatar/178/details/374345/qatar-launches-genome-project〉. 〈http://www.theaustralian.com.au/national-affairs/garvan-telstra-and-the-government-in-talks-over-genome-project〉. Jordan, 2010, Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer, Br. J. Pharmacol., 147, S269 Stegmeier, 2010, Targeted cancer therapies in the twenty-first century: lessons from imatinib, Clin. Pharmacol. Ther., 87, 543, 10.1038/clpt.2009.297 Jones, 2009, Emerging treatments in cystic fibrosis, Drugs, 69, 1903, 10.2165/11318500-000000000-00000 〈http://www.phrma.org/sites/default/files/pdf/pmc-tufts-backgrounder.pdf〉. Pfeffer, 2014, Curcumin: Towards molecularly targeted chemoprevention of cancer, New Horiz. Transl. Med., 2, 20, 10.1016/j.nhtm.2014.08.005 Paik, 2004, A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer, N. Engl. J. Med., 351, 2817, 10.1056/NEJMoa041588 〈http://www.ox.ac.uk/news/2013-03-25-46-gene-sequencing-test-cancer-patients-nhs〉. W. Ou, J. Sheldon, Oracle Health Sciences Translational Research Center, “A Translational Medicine Platform to Address the Big Data Challenge”, Oracle 〈http://data.worldbank.org/indicator/SH.XPD.TOTL.ZS〉. Nadauld, 2015, Precision medicine to improve survival without increasing costs in advanced cancer patients, J. Clin. Oncol., 33, e17641, 10.1200/jco.2015.33.15_suppl.e17641